Core Viewpoint - Fosen Pharmaceutical (01652.HK) has received approval from the National Medical Products Administration of China for its potassium hydrogen phosphate injection, branded as "Shanweixi," which is intended as a phosphate supplement [1] Group 1: Product Details - The potassium hydrogen phosphate injection is primarily used for parenteral nutrition when oral or enteral nutrition is not feasible, insufficient, or contraindicated [1] - It is also indicated for adults and children suffering from hypophosphatemia [1] - The product is classified as a Category B item under the National Medical Insurance Bureau, highlighting its safety, rapid absorption, dual phosphate supplementation, and alignment with multiple clinical guidelines [1]
福森药业(01652.HK)“复合磷酸氢钾注射液”获批上市